News Conference News CRT 2025 AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years L.A. McKeown March 10, 2025
News Conference News CRT 2023 In CABG/PCI Decisions for Left Main Disease, Diabetes ‘Still Matters’ Yael L. Maxwell March 01, 2023
News Conference News BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years Caitlin E. Cox March 02, 2022
News Conference News CRT 2021 BIOSTEMI at 2 Years: Orsiro Continues to Lower TLF in STEMI Patients Caitlin E. Cox March 16, 2021
News Conference News CRT 2020 Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback Michael O'Riordan February 28, 2020
News Conference News CRT 2020 Good Coronary Collateral Circulation? Better LVEF and Survival After STEMI Michael O'Riordan February 24, 2020
News Conference News CRT 2019 CABG vs PCI in Left Main Disease: The Debate Continues Yael L. Maxwell March 12, 2019
News Conference News CRT 2019 ORBITA Absorbed: Principal Investigator Reflects on How Results Have Changed Her Practice Yael L. Maxwell March 07, 2019
News Conference News CRT 2019 Adverse Events Reports for Guide Extension Catheter Should Spur Cautious Use Yael L. Maxwell March 05, 2019
News Conference News CRT 2018 Time to Shine: ‘Historic’ All-Female Team Takes Over Live Case at CRT 2018 Michael O'Riordan March 06, 2018
News Conference News CRT 2018 Acute MI Patients With Paraplegia Rarely Get Revascularization, Face Higher Risk of Death Shelley Wood March 05, 2018
News Conference News CRT 2016 STEMI Mortality Risk Doubled in Women, Even in North America, Europe Shelley Wood February 20, 2016